NCT07397598

Brief Summary

Liver transplant (LT) recipients with a history of alcohol-related liver disease (ALD) may encounter various psychosocial and medical challenges during post-LT recovery, even beyond the initial post-transplant period. Effective and sustainable interventions will be crucial for improving patient outcomes. This clinical trial will examine the impact of peer support specialists (PSS) on the recovery experience of individuals who received LT for ALD. The trial seeks to answer two main questions:

  • Are LT recipients who work with PSS less likely to resume alcohol use or tend to drink less overall?
  • Do LT recipients who work with PSS engage more with recommended medical care and have better overall survival?

Trial Health

63
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
95

participants targeted

Target at P50-P75 for not_applicable

Timeline
38mo left

Started May 2026

Typical duration for not_applicable

Geographic Reach
1 country

1 active site

Status
not yet recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress1%
May 2026Jun 2029

First Submitted

Initial submission to the registry

February 2, 2026

Completed
7 days until next milestone

First Posted

Study publicly available on registry

February 9, 2026

Completed
3 months until next milestone

Study Start

First participant enrolled

May 1, 2026

Completed
3.1 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

June 1, 2029

Expected
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

June 1, 2029

Last Updated

March 17, 2026

Status Verified

March 1, 2026

Enrollment Period

3.1 years

First QC Date

February 2, 2026

Last Update Submit

March 16, 2026

Conditions

Keywords

Alcohol use disorderAlcohol Related Liver DiseaseLiver transplant recipientPeer support specialist

Outcome Measures

Primary Outcomes (1)

  • Alcohol Consumption

    Any use or excessive use (i.e., \>7/\>14 drinks per week for women/men) by biomarker or self-report

    Up to 1 year

Secondary Outcomes (2)

  • Liver Transplant Medical Treatment Engagement

    Up to 1 year

  • Overall Post-Liver Transplant Survival

    Up to 1 year

Study Arms (1)

Peer Support Specialist (PSS)

EXPERIMENTAL
Behavioral: Peer Support

Interventions

Peer SupportBEHAVIORAL

The study will recruit PSS based on lived experiences with ALD/LT and interpersonal skills. The PSS will receive tailored skills training from the study team in areas such as delivering brief counseling, active listening, and maintaining confidentiality. Participants will meet regularly with a PSS between standard clinic visits throughout a one-year study period. The PSS will deliver brief counseling interventions at each session. Study investigators will meet with the PSS at scheduled intervals to review progress. Study investigators will also review up to 20% of the audio recordings of sessions between PSS and study participants to assess fidelity to the intervention protocol.

Peer Support Specialist (PSS)

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • English speakers
  • Received a liver transplant for alcohol-associated liver disease
  • Has 1 to 3 years of continuous alcohol abstinence at the time of trial entry

You may not qualify if:

  • Liver transplant recipients without a history of alcohol-associated liver disease
  • Inability to provide informed consent
  • Active participation in a separate intervention trial for alcohol use disorder

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Johns Hopkins University School of Medicine

Baltimore, Maryland, 21287, United States

Location

MeSH Terms

Conditions

Alcoholism

Condition Hierarchy (Ancestors)

Alcohol-Related DisordersSubstance-Related DisordersChemically-Induced DisordersMental Disorders

Study Officials

  • Po-Hung Chen, MD, PhD

    Johns Hopkins University

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Po-Hung Chen, MD, PhD

CONTACT

Mary E. McCaul, PhD

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NA
Masking
NONE
Purpose
TREATMENT
Intervention Model
SINGLE GROUP
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

February 2, 2026

First Posted

February 9, 2026

Study Start

May 1, 2026

Primary Completion (Estimated)

June 1, 2029

Study Completion (Estimated)

June 1, 2029

Last Updated

March 17, 2026

Record last verified: 2026-03

Data Sharing

IPD Sharing
Will share

Patient reported outcomes and phosphatidylethanol biomarker results

Time Frame
Data will be shared with the general research community at the time of an associated publication, or the end of the award/grant period, whichever comes first. Data will be shared indefinitely.
Access Criteria
Summaries of NIAAA Data Archive (NIAAADA) data are publicly available to anyone through the NDA Query Tool without an account. Access to individual participant data and supporting documentation is limited to qualified researchers who create an NDA account and submit a Data Access Request (DAR), including completion of the NDA Data Use Certification (DUC). Requests are reviewed by a NIAAA committee to ensure responsible data use. Individual-level data are accessed through the NDA Query Tool once approval is granted.
More information

Locations